Related Experiment Video
Updated: Apr 21, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
New hope in the search for Ebola virus treatments
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Abstract:
Because of its lethality, the Ebola virus often appears to be an invincible adversary. In Nature, Qiu et al. (2014) recently described the complete protection of nonhuman primates from deadly Ebola virus disease, even when treatment was begun as late as 5 days after infection.
More Related Videos
06:59Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
Published on: June 30, 2018
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Cross-reactivity
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmaceutical Poisoning: Treatment Strategies
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Inhibitors of Viral Protein Synthesis
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care